FR2480122A1 - Procede de preparation d'une glycoproteine a activite immunosupressive, glycoproteine telle qu'ainsi obtenue et medicament la renfermant - Google Patents
Procede de preparation d'une glycoproteine a activite immunosupressive, glycoproteine telle qu'ainsi obtenue et medicament la renfermant Download PDFInfo
- Publication number
- FR2480122A1 FR2480122A1 FR8107182A FR8107182A FR2480122A1 FR 2480122 A1 FR2480122 A1 FR 2480122A1 FR 8107182 A FR8107182 A FR 8107182A FR 8107182 A FR8107182 A FR 8107182A FR 2480122 A1 FR2480122 A1 FR 2480122A1
- Authority
- FR
- France
- Prior art keywords
- glycoprotein
- serum
- isoelectric
- ascites
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000288 Glycoproteins Proteins 0.000 title claims abstract description 35
- 102000003886 Glycoproteins Human genes 0.000 title claims abstract description 35
- 230000001506 immunosuppresive effect Effects 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 241001465754 Metazoa Species 0.000 claims abstract description 16
- 210000002966 serum Anatomy 0.000 claims abstract description 16
- 206010003445 Ascites Diseases 0.000 claims description 15
- 206010028980 Neoplasm Diseases 0.000 claims description 10
- 201000011510 cancer Diseases 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 241000282412 Homo Species 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000035584 blastogenesis Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 101800000263 Acidic protein Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 108010047620 Phytohemagglutinins Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000005104 human peripheral blood lymphocyte Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000001885 phytohemagglutinin Effects 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000004641 Fetal Proteins Human genes 0.000 description 1
- 108010003471 Fetal Proteins Proteins 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4765580A JPS56145297A (en) | 1980-04-11 | 1980-04-11 | Preparative method of glycoprotein having immunosupressing activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2480122A1 true FR2480122A1 (fr) | 1981-10-16 |
| FR2480122B1 FR2480122B1 (enrdf_load_stackoverflow) | 1983-11-10 |
Family
ID=12781263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8107182A Granted FR2480122A1 (fr) | 1980-04-11 | 1981-04-09 | Procede de preparation d'une glycoproteine a activite immunosupressive, glycoproteine telle qu'ainsi obtenue et medicament la renfermant |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS56145297A (enrdf_load_stackoverflow) |
| DE (1) | DE3114641A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2480122A1 (enrdf_load_stackoverflow) |
| GB (1) | GB2078229B (enrdf_load_stackoverflow) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ199752A (en) * | 1981-02-27 | 1984-11-09 | Otsuka Pharma Co Ltd | Glycoproteins and immunoactive compositions |
| JPH08239324A (ja) * | 1995-03-03 | 1996-09-17 | Fusanori Hamashima | 免疫抑制剤 |
| RU2122863C1 (ru) * | 1996-09-26 | 1998-12-10 | Институт ревматологии РАМН | Способ получения иммунорегуляторного глобулина |
| RU2136695C1 (ru) * | 1998-03-18 | 1999-09-10 | ЗАОПП "Эндо-Фарм-А" | Сывороточный гликопротеин, обладающий биологической активностью в сверхмалых дозах |
| JPH11349488A (ja) * | 1998-06-01 | 1999-12-21 | Hisamitsu Pharmaceut Co Inc | クラスタリンを含有する免疫抑制剤 |
| BG65084B1 (bg) * | 2002-03-13 | 2007-02-28 | Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" | Нов клас биоактивни гликопротеини |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2191885A1 (enrdf_load_stackoverflow) * | 1972-07-10 | 1974-02-08 | Bjorklund Knut | |
| FR2381058A1 (fr) * | 1977-02-18 | 1978-09-15 | Research Corp | Glycoproteines specifiques des tumeurs et procede pour la detection des cancers tumorigenes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2101041B1 (enrdf_load_stackoverflow) * | 1970-08-12 | 1974-02-01 | Cassenne Lab Sa | |
| JPS5344611A (en) * | 1976-10-01 | 1978-04-21 | Koyama Yasuo | Preparation of acidic protein having immune control activity |
| DE2726886A1 (de) * | 1977-06-15 | 1979-01-18 | Behringwerke Ag | Neues glykoprotein und verfahren zu dessen herstellung |
-
1980
- 1980-04-11 JP JP4765580A patent/JPS56145297A/ja active Granted
-
1981
- 1981-04-09 FR FR8107182A patent/FR2480122A1/fr active Granted
- 1981-04-10 DE DE19813114641 patent/DE3114641A1/de not_active Withdrawn
- 1981-04-10 GB GB8111349A patent/GB2078229B/en not_active Expired
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2191885A1 (enrdf_load_stackoverflow) * | 1972-07-10 | 1974-02-08 | Bjorklund Knut | |
| FR2381058A1 (fr) * | 1977-02-18 | 1978-09-15 | Research Corp | Glycoproteines specifiques des tumeurs et procede pour la detection des cancers tumorigenes |
Non-Patent Citations (2)
| Title |
|---|
| CA1974 * |
| EXBK/76 * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2078229B (en) | 1983-08-10 |
| DE3114641A1 (de) | 1982-02-11 |
| JPS56145297A (en) | 1981-11-11 |
| JPS6346760B2 (enrdf_load_stackoverflow) | 1988-09-19 |
| FR2480122B1 (enrdf_load_stackoverflow) | 1983-11-10 |
| GB2078229A (en) | 1982-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH664974A5 (fr) | Production du facteur de lyse des cellules-cibles. | |
| FR2522267A1 (fr) | Glycoproteines a activite antitumorale, leur procede de preparation et leur application therapeutique | |
| JPS63146833A (ja) | 後生的なグリコシル化最終産物を除去する為の方法及び薬剤 | |
| JP2975997B2 (ja) | プロアントシアニジンａおよびその誘導体 | |
| FR2484258A1 (fr) | Agent immunotherapique pour tumeurs, avec du lipopolysaccharide comme composant actif, et procede de preparation de cet agent | |
| FR2497229A1 (fr) | Procede de preparation d'un derive polysaccharidique de fibrinolysine | |
| JP2004307458A (ja) | 抗癌、免疫及び造血機能増進効果と酸化的生体損傷の抑制効果を持った生薬組成物とその製造方法 | |
| WO1982001131A1 (en) | New biologically active substances,production thereof from human casein and compositions containing them | |
| FR2460669A1 (fr) | Compositions pharmaceutiques a base de rifamycine sv et ses sels adaptes au traitement du rhumatisme articulaire et procede pour leur preparation | |
| FR2480122A1 (fr) | Procede de preparation d'une glycoproteine a activite immunosupressive, glycoproteine telle qu'ainsi obtenue et medicament la renfermant | |
| FR2522001A1 (fr) | Polysaccharides, leur preparation et compositions therapeutiques contenant ces produits | |
| EP0349469A1 (fr) | Produit pharmaceutique doté d'activité de régénération de l'épiderme basé sur le principe actif du mimosa tenuiflora et procédé d'obtention correspondant | |
| EP0601911A1 (fr) | Acylaminoacides obtenus par l'acylation d'hydrolysats de protéines et compositions anti-microbiennes, antiparasitaires ou cosmétiques en contenant | |
| FR2556220A1 (fr) | Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leur production et leurs utilisations | |
| CH639396A5 (fr) | Substance dite ''ks-2-b'' et procede pour sa fabrication. | |
| EP0316322B1 (fr) | Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopo etiques, procedes pour son obtention et ses applications | |
| FR2522266A1 (fr) | Procede de preparation d'un agent fibrinolytiquement actif et agent obtenu | |
| FR2500753A1 (fr) | Glycoproteine ayant une activite biologique, procede pour la preparer et compositions pharmaceutiques immunoactives la contenant | |
| JP2835504B2 (ja) | 新規なペプチドおよび活性化酸素阻害剤 | |
| CA3060365A1 (fr) | Derives amides des acides polycafeoylquiniques, procede de preparation et utilisations | |
| CA1250810A (fr) | Hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent | |
| RU2078345C1 (ru) | Способ получения сывороточного белкового препарата, влияющего на активность окислительно-энергетического обмена | |
| FR2507476A1 (fr) | Procede de preparation de nouvelles substances actives du placenta a usage therapeutique | |
| RU2341272C1 (ru) | Средство для неспецифической иммунотерапии | |
| CN1059896C (zh) | 肿瘤逆转剂组成物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |